Articoli con mandati relativi all'accesso pubblico - Prof Jonathan M SchottUlteriori informazioni
Non disponibili pubblicamente: 16
Controlla
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
T Skillbäck, B Farahmand, JW Bartlett, C Rosén, N Mattsson, K Nägga, ...
Neurology 83 (21), 1945-1953, 2014
Mandati: Swedish Research Council
Controlla
Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales
L Harper, F Barkhof, NC Fox, JM Schott
Journal of Neurology, Neurosurgery & Psychiatry 86 (11), 1225-1233, 2015
Mandati: Alzheimers's UK, National Institute for Health Research, UK
Controlla
Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1‐42
JM Schott, JW Bartlett, NC Fox, J Barnes, ...
Annals of neurology 68 (6), 825-834, 2010
Mandati: US National Institutes of Health
Controlla
What is the clinically relevant change on the ADAS-Cog?
A Schrag, JM Schott, Alzheimer's Disease Neuroimaging Initiative
Journal of Neurology, Neurosurgery & Psychiatry 83 (2), 171-173, 2012
Mandati: US National Institutes of Health
Controlla
Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis
RW Paterson, J Toombs, CF Slattery, JM Nicholas, U Andreasson, ...
Journal of neurology 262, 2722-2730, 2015
Mandati: Swedish Research Council, Alzheimers's UK, UK Economic and Social Research …
Controlla
Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers
M Lehmann, EL Koedam, J Barnes, JW Bartlett, F Barkhof, MP Wattjes, ...
Neurobiology of aging 34 (1), 73-82, 2013
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Controlla
Learning imaging biomarker trajectories from noisy Alzheimer’s disease data using a Bayesian multilevel model
NP Oxtoby, AL Young, NC Fox, ...
Bayesian and grAphical Models for Biomedical Imaging: First International …, 2014
Mandati: US National Institutes of Health
Controlla
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
AL Young, NP Oxtoby, S Garbarino, NC Fox, F Barkhof, JM Schott, ...
Nature Reviews Neuroscience 25 (2), 111-130, 2024
Mandati: Alzheimers's UK, UK Medical Research Council, National Institute for Health …
Controlla
Cerebrospinal fluid in the dementias
H Zetterberg, JD Rohrer, JM Schott
Handbook of Clinical Neurology 146, 85-97, 2018
Mandati: Knut and Alice Wallenberg Foundation, Swedish Research Council, Alzheimers's …
Controlla
Biomarker modelling of early molecular changes in Alzheimer’s disease
RW Paterson, J Toombs, CF Slattery, JM Schott, H Zetterberg
Molecular diagnosis & therapy 18, 213-227, 2014
Mandati: Swedish Research Council, National Institute for Health Research, UK
Controlla
A clinicopathologic study of movement disorders in frontotemporal lobar degeneration
E de Pablo‐Fernández, B González‐Herrero, D Cerdán Santacruz, ...
Movement Disorders 36 (3), 632-641, 2021
Mandati: Canadian Institutes of Health Research, Alzheimers's UK, UK Medical Research …
Controlla
Infection, inflammation and A lzheimer's disease
JM Schott
European Journal of Neurology 22 (12), 1503-1504, 2015
Mandati: Alzheimers's UK
Controlla
Imaging the ageing brain: identifying early disease or opening Pandora's box?
JM Schott
The Lancet. Neurology 16 (6), 411-413, 2017
Mandati: Alzheimers's UK, UK Engineering and Physical Sciences Research Council, UK …
Controlla
Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy
CRS Belder, D Boche, JAR Nicoll, Z Jaunmuktane, H Zetterberg, ...
The Lancet Neurology 23 (10), 1025-1034, 2024
Mandati: UK Engineering and Physical Sciences Research Council, UK Medical Research …
Controlla
Cerebrospinal fluid biomarkers in Alzheimer’s Disease
H Zetterberg, JM Schott
Immunotherapy and Biomarkers in Neurodegenerative Disorders, 153-179, 2016
Mandati: Swedish Research Council, Alzheimers's UK, National Institute for Health …
Controlla
Preparing for disease-modifying dementia therapies in the UK
C Cooper, CR Marshall, JM Schott, S Banerjee
Nature Reviews Neurology, 1-2, 2024
Mandati: National Institute for Health Research, UK
Disponibili pubblicamente: 305
Controlla
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
EAD Init
Nature Genetics 45 (12), 1452-8, 2013
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Controlla
Alzheimer's disease
CA Lane, J Hardy, JM Schott
European journal of neurology 25 (1), 59-70, 2018
Mandati: Alzheimers's UK, Versus Arthritis, UK, UK Engineering and Physical Sciences …
Controlla
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Mandati: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Controlla
Analysis of shared heritability in common disorders of the brain
Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ...
Science 360 (6395), eaap8757, 2018
Mandati: US National Institutes of Health, Swedish Research Council, Alzheimers's UK …
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software